This new AI tool can detect 9 types of dementia from single brain scan
The tool, StateViewer, not only helped in early detection but also provided accurate diagnosis -- it identified the dementia type in 88 per cent of cases, including Alzheimer's disease.
It also enabled clinicians to interpret brain scans nearly twice as fast and with up to three times greater accuracy than standard workflows, according to the research, published online in the journal Neurology.
Researchers from the Mayo Clinic trained and tested the AI on more than 3,600 scans, including images from patients with dementia and people without cognitive impairment.
Currently, diagnosing dementia requires cognitive tests, blood draws, imaging, and clinical interviews, and yet, distinguishing conditions such as Alzheimer's, Lewy body dementia and frontotemporal dementia remains a challenge.
'Every patient who walks into my clinic carries a unique story shaped by the brain's complexity,' said David Jones, a Mayo Clinic neurologist.
'StateViewer reflects that commitment -- a step toward earlier understanding, more precise treatment, and, one day, changing the course of these diseases,' added Jones, director of the Mayo Clinic Neurology Artificial Intelligence Programme.
The tool analyses a fluorodeoxyglucose positron emission tomography (FDG-PET) scan, which shows how the brain uses glucose for energy. It then compares the scan to a large database of scans from people with confirmed dementia diagnoses and identifies patterns that match specific types, or combinations, of dementia.
While Alzheimer's affects memory and processing regions, Lewy body dementia involves areas tied to attention and movement. Frontotemporal dementia alters regions responsible for language and behaviour.
StateViewer displays these patterns through colour-coded brain maps that highlight key areas of brain activity, giving all clinicians, even those without neurology training, a visual explanation of what the AI sees and how it supports the diagnosis.
Dementia affects more than 55 million people worldwide, with nearly 10 million new cases each year. Alzheimer's disease, the most common form, is now the fifth-leading cause of death globally.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Hindu
7 hours ago
- The Hindu
Alzheimer's disease: Researchers find two cancer drugs reverse damaged gene behaviour in mice
A study that compared gene behaviour in Alzheimer's disease with that caused by 1,300 drugs approved for use in the US has found that a combination of two cancer drugs could slow the neurodegenerative disease in mice, indicating a promise in reversing symptoms in humans. Alzheimer's disease is an ageing-related disorder in which cognitive function steadily declines, affecting speech and memory, and eventually can interfere with everyday activities. Scientists at the University of California, San Francisco, and Gladstone Institutes in the US first saw how gene behaviour was affected in Alzheimer's disease in a single brain cell. The researchers then looked at 1,300 drugs approved by the US Food and Drug Administration (FDA) and which of them reversed the damage. The next stage of the study, published in the journal 'Cell', analysed electronic medical records of about 1.4 million patients and found that patients who took some of these drugs for treating conditions other than Alzheimer's disease were less likely to get the ageing-related neurological disorder. Testing the top two drug candidates -- 'letrozole' and 'irinotecan', both of which are cancer medications -- in a mouse model having Alzheimer's disease, the researchers found that brain degeneration was reduced and a restored ability to remember. Letrozole is usually prescribed for treating breast cancer, and irinotecan for colon and lung cancer. The combined effects of two drugs were found to reverse damaged gene behaviour in neurons and glia (a type of brain cells that surround and support neurons). Further, toxic clumps of proteins and brain degeneration -- hallmark features of Alzheimer's -- were found to be reduced and memory restored, the researchers said. The team added that out of 1,300 drugs, 86 reversed gene behaviour changes in one type of brain cell and 25 reversed them in other types. However, only 10 had been approved for use in humans by the FDA. "Thanks to all these existing data sources, we went from 1,300 drugs, to 86, to 10, to just five," said lead author Yaqiao Li, a postdoctoral scholar at Gladstone Institutes. "Alzheimer's disease comes with complex changes to the brain which has made it tough to study and treat, but our computational tools opened up the possibility of tackling the complexity directly," said co-senior author Marina Sirota, professor of paediatrics and an interim director at the University of California. Co-senior author Yadong Huang, director of the center for translational advancement at Gladstone Institutes, said, "Alzheimer's is likely the result of numerous alterations in many genes and proteins that, together, disrupt brain health." "This makes it very challenging for drug development -- which traditionally produces one drug for a single gene or protein that drives disease," Huang said. The electronic medical records analysed in the study came from the University of California's Health Data Warehouse, which includes anonymised health information on 1.4 million people over the age of 65.
India Today
8 hours ago
- India Today
India's elderly population to double by 2050: How to slow cognitive decline
As we grow older, it's natural for the body to change - and the brain is no exception. After the age of 60, many people notice that their memory isn't as sharp, learning new things takes longer, and decision-making can become is known as cognitive decline, and it's something more and more people are facing as India's population here's the good news: cognitive decline is not something we have to simply accept. Doctors say there are many simple steps we can take to protect our brain and stay mentally fit in our later DO COGNITIVE ABILITIES DECLINE WITH AGE?According to Dr. Aparna Gupta, Associate Director of Neurology at Indian Spinal Injuries Centre, New Delhi, the brain naturally changes with age. Nerve cells (called neurons) shrink, and the connections between them flow to the brain also reduces, especially in the parts that help with memory and quick thinking.'This is why older people may find it harder to process new information quickly, even though their life knowledge and experience stay strong,' says Dr. some cases, more serious brain conditions like Alzheimer's or dementia can develop. These affect nearly 7.4% of elderly Indians and are caused by a buildup of toxic proteins in the brain and slower brain AGEING CHALLENGEDr. Ravindra Srivastava, Senior Consultant in Neurosciences at Sharda Care Healthcity, Greater Noida, points out that India's elderly population is rising fast — expected to more than double by means more people may face problems like memory loss, difficulty concentrating, and trouble making decisions.'Cognitive decline affects not just memory but also a person's independence, confidence, and overall health. It can place a heavy burden on families and healthcare systems,' he CAN YOU DO TO PROTECT YOUR BRAIN?While we can't stop ageing, we can slow down how it affects our brain. Both doctors agree that simple lifestyle changes can make a big physically activeEven moderate exercise like walking, yoga, or dancing helps improve memory and an antioxidant-rich dietFoods rich in antioxidants — such as colourful fruits and vegetables — support brain health. Avoid too much sugar and processed wellGetting enough good-quality sleep allows the brain to rest and your mind busyRead, do puzzles, learn something new, or talk to friends and family. Mental stimulation keeps your brain connections health conditionsControl blood pressure, diabetes, and cholesterol. These all affect brain health check-upsEarly screening can catch signs of dementia or other problems before they become health should be a priority, says Dr. Srivastava, not just for older adults but for families and communities too. 'A healthy brain means a better quality of life, even in old age,' he the right habits and timely care, staying sharp and independent is very much possible — even well into your 70s and beyond.- EndsTrending Reel
Time of India
8 hours ago
- Time of India
Bruce Willis can't speak, read, and walk. Here's what happened to the 'Die Hard' actor
Bruce Willis, the celebrated actor of 'Die Hard' fame, is reportedly battling a severe decline due to frontotemporal dementia (FTD). The 70-year-old star, who retired in 2022 following an aphasia diagnosis, has now lost the ability to speak, read, and walk. This heartbreaking progression of FTD requires him to have full-time care, and he no longer remembers his illustrious career. Tired of too many ads? Remove Ads What is FTD Tired of too many ads? Remove Ads Behavioral and personality changes – acting impulsively, losing empathy, neglecting hygiene, overeating, or showing lack of motivation Language difficulties – speaking slowly, using words incorrectly, or struggling with sentence structure Cognitive challenges – issues with focus, planning, or organizing tasks Physical symptoms (in later stages) – stiff or slowed movement, difficulty swallowing, loss of bladder or bowel control, and muscle weakness Legendary actor Bruce Willis, known for iconic roles in Die Hard, The Sixth Sense, and Pulp Fiction, is facing a severe health decline. Recent reports reveal that the 70-year-old star can no longer speak, read, or walk due to the rapid progression of frontotemporal dementia (FTD), a degenerative brain retired from acting in 2022 after being diagnosed with aphasia, a condition that affects communication. In early 2023, his family confirmed that his condition had progressed into FTD, a more serious neurological disorder that gradually erodes speech, motor functions, and affects the brain's frontal and temporal lobes — areas responsible for language, movement, and emotional regulation. As the disease worsens, individuals lose their ability to communicate, recognize words, or perform simple physical known for his sharp wit and physicality on screen, Willis now requires full-time care. He can no longer hold conversations, walk unaided, or recall his past — including his own successful film career. His family, who has remained by his side throughout, has asked for privacy as they navigate this challenging dementia (FTD) typically develops between the ages of 45 and 64 and is often misdiagnosed, either as a psychiatric disorder or as Alzheimer's disease. Unlike Alzheimer's, which primarily affects memory in the early stages, FTD begins with noticeable changes in personality, behavior, or language signs may include difficulty finding the right words, changes in mood, or impulsive and socially inappropriate behavior. As the condition progresses, individuals may lose the ability to speak, read, or write. Muscle control also deteriorates, eventually making basic movement and swallowing difficult. In the advanced stages, patients often require constant, round-the-clock Willis's diagnosis has brought global attention to this lesser-known form of dementia. Medical experts emphasize the value of early detection, speech and physical therapy, and strong emotional and caregiving support networks to help manage the disease's to the Mayo Clinic, FTD occurs when parts of the brain's frontal and temporal lobes shrink — a process known as atrophy. The symptoms vary depending on which region is most affected. Some people may become emotionally detached, impulsive, or socially inappropriate, while others struggle to form coherent sentences or lose the ability to speak accounts for roughly 10% to 20% of all dementia cases and often goes unrecognized due to its early onset and atypical symptoms. While memory problems usually appear much later, initial symptoms can include:
